Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 29.87 is 47% above its 5-year average of 20.36, near the high end of its 5-year range (11.08–29.87).
17.39% above its 12-month average of 25.45.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 7.62.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T00:15:54.139Z. Historical observations retain their original dates. Historical series through 2026-09-11.
EARNINGS PER SHARE (EPS)
29.87
EARNINGS PER SHARE (EPS) AVG TTM
25.45
EARNINGS PER SHARE (EPS) AVG 3Y
22.39
EARNINGS PER SHARE (EPS) AVG 5Y
20.36
EARNINGS PER SHARE (EPS) AVG 10Y
14.81
EARNINGS PER SHARE (EPS) AVG 15Y
11.41
EARNINGS PER SHARE (EPS) AVG 20Y
8.37
CURRENT VS TTM AVG
+17.39%
CURRENT VS 3Y AVG
+33.39%
CURRENT VS 5Y AVG
+46.71%
CURRENT VS 10Y AVG
+101.65%
CURRENT VS 15Y AVG
+161.79%
CURRENT VS 20Y AVG
+256.96%
HCA Healthcare, Inc.
Market Cap
$92.12B
Earnings Per Share (EPS)
29.87
TTM Avg
25.45
3Y Avg
22.39
5Y Avg
20.36
Market Cap
$92.00B
Earnings Per Share (EPS)
22.50
TTM Avg
25.49
3Y Avg
25.23
5Y Avg
24.07
Market Cap
$81.77B
Earnings Per Share (EPS)
40.43
TTM Avg
41.98
3Y Avg
40.38
5Y Avg
45.10
Market Cap
$106.65B
Earnings Per Share (EPS)
37.37
TTM Avg
32.20
3Y Avg
28.04
5Y Avg
15.41
Market Cap
$76.64B
Earnings Per Share (EPS)
24.16
TTM Avg
17.27
3Y Avg
18.45
5Y Avg
18.81
Market Cap
$108.06B
Earnings Per Share (EPS)
9.65
TTM Avg
8.18
3Y Avg
7.73
5Y Avg
6.75
Market Cap
$66.96B
Earnings Per Share (EPS)
2.46
TTM Avg
1.61
3Y Avg
1.19
5Y Avg
0.89
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCA Healthcare, Inc. (HCA) | $92.12B | 29.87 | 25.45 | 22.39 | 20.36 |
| Elevance Health Inc. (ELV)vs › | $92.00B | 22.50 | 25.49 | 25.23 | 24.07 |
| GSK plc (GSK)vs › | $100.28B | 3.16 | 2.69 | 4.37 | 4.18 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.77B | 40.43 | 41.98 | 40.38 | 45.10 |
| Sanofi (SNY)vs › | $104.04B | 0.56 | 3.01 | 2.95 | 3.44 |
| McKesson Corporation (MCK)vs › | $106.65B | 37.37 | 32.20 | 28.04 | 15.41 |
| Cigna Corporation (CI)vs › | $76.64B | 24.16 | 17.27 | 18.45 | 18.81 |
| Stryker Corporation (SYK)vs › | $108.06B | 9.65 | 8.18 | 7.73 | 6.75 |
| Boston Scientific Corporation (BSX)vs › | $66.96B | 2.46 | 1.61 | 1.19 | 0.89 |
| Medtronic plc (MDT)vs › | $120.07B | 4.06 | 3.69 | 3.25 | 3.23 |
Trailing EPS (TTM)
$29.87
Forward EPS (Est.)
$29.47
P/E Ratio
14.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 28.62 |
| 2024-12-31 | 22.27 |
| 2023-12-31 | 19.24 |
| 2022-12-31 | 19.44 |
| 2021-12-31 | 21.51 |
| 2020-12-31 | 11.08 |
| 2019-12-31 | 10.27 |
| 2018-12-31 | 11.04 |
| 2017-12-31 | 6.33 |
| 2016-12-31 | 7.80 |
| 2015-12-31 | 5.34 |
| 2014-12-31 | 4.46 |
| 2013-12-31 | 3.54 |
| 2012-12-31 | 3.62 |
| 2011-12-31 | 5.17 |
| 2010-12-31 | 2.83 |
| 2009-12-31 | 3.08 |
| 2008-12-31 | 1.97 |
| 2007-12-31 | 2.56 |
| 2006-12-31 | 2.57 |
| 2005-12-31 | 3.24 |
| 2004-12-31 | 2.62 |
| 2003-12-31 | 2.66 |
| 2002-12-31 | 1.63 |
| 2001-12-31 | 1.69 |
| 2000-12-31 | 0.39 |
| 1999-12-31 | 1.12 |
| 1998-12-31 | 0.73 |
| 1997-12-31 | -0.46 |
| 1996-12-31 | 2.24 |
